DPP4 and type 2 diabetes mellitus: Despite their relatively high cost, DPP-4 inhibitors are frequently prescribed as a third-line add-on therapy for patients with type 2 diabetes who exhibit inadequate glycemic control on combination treatment with metformin and sulfonylureas.